Enolase 1 (eno1) compositions and uses thereof
US-2015359861-A1 · Dec 17, 2015 · US
US10640592B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10640592-B2 |
| Application number | US-201515768470-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 13, 2015 |
| Priority date | Oct 13, 2015 |
| Publication date | May 5, 2020 |
| Grant date | May 5, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are the cation polymers capable of removing their positive charges in oxidative conditions, preparation methods, and applications as gene delivery carriers. The oxidation-responsive unit is the p-(boronic acid or ester)benzylammonium, which upon oxidation eliminates p-hydroxymethlphenol and thus converts in a tertiary amine. Compared with the prior art, different from a common quaternary amination carrier, the synthesized charge reversal type gene delivery carrier for oxidative response of the present invention has a large quantity of positive charges and can well coat a DNA, but the positive charges can be removed under the condition of intracellular oxidation when the charge reversal type gene delivery carrier enters a cell, a charge reverse is triggered, the positive charges turn to negative charges, and the DNA is quickly released for transfection. The carrier is efficient, low in toxicity, and good in application prospect.
Opening claim text (preview).
What is claimed is: 1. A cationic polymer capable of removing positive charges through oxidative response, comprising the following moiety: wherein: R 1 and R 2 are independently selected from the group consisting of C 1-6 alkyl or aryl; R 3 and R 4 are independently selected from the group consisting of hydrogen, C 1-6 alkyl or acyl; and m is a positive integer from 1 to 4; wherein the cationic polymer is obtained from reactions between polyacrylate, polymethacrylate or other primary or secondary amino-containing polymers and a compound containing benzylboronic acid or ester; and wherein the primary or secondary amino-containing polymers comprise poly[2-(N,N-disubstituted-amino)ethyl acrylate], polyethyleneimine (PEI) and poly(amidoamine) dendrimers (PAMAM). 2. The cationic polymer of claim 1 , wherein R 3 and R 4 are selected from hydrogen, acetyl or formyl, and R 1 and R 2 are methyl or ethyl. 3. The cationic polymer of claim 1 , wherein the polymer is used for the delivery of deoxyribonucleic acids and oligonucleotides. 4. The cationic polymer of claim 1 , wherein the polymer is used for the delivery of taxol. 5. The polymer of claim 1 , wherein the polymer comprises an anion, which is bromide or chloride ion.
Polyalkylene(poly)amines · CPC title
the non-active part being polymeric · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes · CPC title
using microencapsulation, e.g. using {amphiphile} liposome vesicle · CPC title
Esters containing nitrogen {, e.g. N,N-dimethylaminoethyl (meth)acrylate} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.